Adjuvant therapies for non-muscle-invasive bladder cancer: advances during BCG shortage
Author:
Publisher
Springer Science and Business Media LLC
Subject
Urology
Link
https://link.springer.com/content/pdf/10.1007/s00345-021-03908-x.pdf
Reference95 articles.
1. Schulz GB, Grimm T, Buchner A, Jokisch F, Kretschmer A, Stief CG et al (2019) Bladder Cancer Stage Development, 2004–2014 in Europe Compared With the United States: Analysis of European Population-based Cancer Registries, the United States SEER Database, and a Large Tertiary Institutional Cohort. Clin Genitourin Cancer. https://doi.org/10.1016/j.clgc.2019.10.008
2. Mossanen M, Gore JL (2014) The burden of bladder cancer care: direct and indirect costs. Curr Opin Urol 24:487–491
3. Soukup V, Čapoun O, Cohen D, Hernández V, Babjuk M, Burger M et al (2017) Prognostic performance and reproducibility of the 1973 and 2004/2016 World Health Organization grading classification systems in non–muscle-invasive bladder cancer: A European Association of Urology Non-muscle Invasive Bladder Cancer Guidelines Panel Syst. Eur Urol 72:801–813
4. Tully KH, Roghmann F, Noldus J, Chen X, Häuser L, Kibel AS et al (2020) Quantifying the overall survival benefit with early radical cystectomy for patients with histologically confirmed t1 non–muscle-invasive bladder cancer. Clin Genitourin Cancer 18:e651–e659
5. Perera M, Papa N, Christidis D, McGrath S, Manning T, Roberts M et al (2017) The impact of the global BCG shortage on treatment patterns: population-based data. BJU Int. https://doi.org/10.1111/bju.14065
Cited by 27 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Adverse drug reactions of intravesical instillation therapy for bladder cancer: based on FDA adverse event reporting system;Expert Opinion on Drug Safety;2024-08-22
2. Economic Impact of Bladder Cancer in the USA;PharmacoEconomics - Open;2024-08-18
3. Mitomycin C vs. Bacillus Calmette–Guerin for treatment of intermediate-risk nonmuscle invasive bladder cancer patients—A comparative analysis from a single center;Urologic Oncology: Seminars and Original Investigations;2024-07
4. Quantitative CT Morphometrics: A Novel Approach for Predicting the Bladder Cancer Grade;Cureus;2024-06-28
5. Intravesical Gemcitabine and Docetaxel Therapy for BCG-Naïve Patients: A Promising Approach to Non-Muscle Invasive Bladder Cancer;Life;2024-06-22
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3